
In vitro fertilization (IVF) is a complex series of procedures used to treat fertility or genetic problems and assist with the conception of a child. During IVF, mature eggs are collected (retrieved) from your ovaries and fertilized by sperm in a lab.
Âé¶¹Ô´´ Analysis and Insights: Global IVF Service Âé¶¹Ô´´
The global IVF Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
In terms of regions, North America is expected to remain the largest market during the forecast period.
Report Covers:
This report presents an overview of global market for IVF Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of IVF Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for IVF Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the IVF Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global IVF Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for IVF Service revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
IVI-RMA Global
Virtus Health
Southern California Reproductive Center
Monash IVF
ManorIVF
Bloom Reproductive Institute
Fertility First
Fertility Associates
Genea Oxford Fertility
Boston IVF
Repromed
The Montreal Fertility Center
Sanatorium HELIOS
Embryolab
Dunya IVF
Klinika Bocian
Morpheus IVF
Manipal Fertility
Cloudnine IVF
Shanghai Ji Ai Genetics & IVF Institute
Segment by Type
Donor Egg IVF Service
Non-Donor Egg IVF Service
Segment by Application
Hospitals
Fertility Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of IVF Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVF Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVF Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global IVF Service Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Donor Egg IVF Service
1.2.3 Non-Donor Egg IVF Service
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global IVF Service Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Fertility Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVF Service Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global IVF Service Growth Trends by Region
2.2.1 IVF Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVF Service Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 IVF Service Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 IVF Service Âé¶¹Ô´´ Dynamics
2.3.1 IVF Service Industry Trends
2.3.2 IVF Service Âé¶¹Ô´´ Drivers
2.3.3 IVF Service Âé¶¹Ô´´ Challenges
2.3.4 IVF Service Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue IVF Service by Players
3.1.1 Global IVF Service Revenue by Players (2019-2024)
3.1.2 Global IVF Service Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global IVF Service Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of IVF Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global IVF Service Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global IVF Service Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVF Service Revenue in 2023
3.5 Global Key Players of IVF Service Head office and Area Served
3.6 Global Key Players of IVF Service, Product and Application
3.7 Global Key Players of IVF Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVF Service Breakdown Data by Type
4.1 Global IVF Service Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global IVF Service Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 IVF Service Breakdown Data by Application
5.1 Global IVF Service Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global IVF Service Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America IVF Service Âé¶¹Ô´´ Size (2019-2030)
6.2 North America IVF Service Âé¶¹Ô´´ Size by Type
6.2.1 North America IVF Service Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America IVF Service Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America IVF Service Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America IVF Service Âé¶¹Ô´´ Size by Application
6.3.1 North America IVF Service Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America IVF Service Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America IVF Service Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America IVF Service Âé¶¹Ô´´ Size by Country
6.4.1 North America IVF Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America IVF Service Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America IVF Service Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe IVF Service Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe IVF Service Âé¶¹Ô´´ Size by Type
7.2.1 Europe IVF Service Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe IVF Service Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe IVF Service Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe IVF Service Âé¶¹Ô´´ Size by Application
7.3.1 Europe IVF Service Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe IVF Service Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe IVF Service Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe IVF Service Âé¶¹Ô´´ Size by Country
7.4.1 Europe IVF Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe IVF Service Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe IVF Service Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China IVF Service Âé¶¹Ô´´ Size (2019-2030)
8.2 China IVF Service Âé¶¹Ô´´ Size by Type
8.2.1 China IVF Service Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China IVF Service Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China IVF Service Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China IVF Service Âé¶¹Ô´´ Size by Application
8.3.1 China IVF Service Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China IVF Service Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China IVF Service Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia IVF Service Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia IVF Service Âé¶¹Ô´´ Size by Type
9.2.1 Asia IVF Service Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia IVF Service Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia IVF Service Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia IVF Service Âé¶¹Ô´´ Size by Application
9.3.1 Asia IVF Service Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia IVF Service Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia IVF Service Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia IVF Service Âé¶¹Ô´´ Size by Region
9.4.1 Asia IVF Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia IVF Service Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia IVF Service Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America IVF Service Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IVI-RMA Global
11.1.1 IVI-RMA Global Company Details
11.1.2 IVI-RMA Global Business Overview
11.1.3 IVI-RMA Global IVF Service Introduction
11.1.4 IVI-RMA Global Revenue in IVF Service Business (2019-2024)
11.1.5 IVI-RMA Global Recent Developments
11.2 Virtus Health
11.2.1 Virtus Health Company Details
11.2.2 Virtus Health Business Overview
11.2.3 Virtus Health IVF Service Introduction
11.2.4 Virtus Health Revenue in IVF Service Business (2019-2024)
11.2.5 Virtus Health Recent Developments
11.3 Southern California Reproductive Center
11.3.1 Southern California Reproductive Center Company Details
11.3.2 Southern California Reproductive Center Business Overview
11.3.3 Southern California Reproductive Center IVF Service Introduction
11.3.4 Southern California Reproductive Center Revenue in IVF Service Business (2019-2024)
11.3.5 Southern California Reproductive Center Recent Developments
11.4 Monash IVF
11.4.1 Monash IVF Company Details
11.4.2 Monash IVF Business Overview
11.4.3 Monash IVF IVF Service Introduction
11.4.4 Monash IVF Revenue in IVF Service Business (2019-2024)
11.4.5 Monash IVF Recent Developments
11.5 ManorIVF
11.5.1 ManorIVF Company Details
11.5.2 ManorIVF Business Overview
11.5.3 ManorIVF IVF Service Introduction
11.5.4 ManorIVF Revenue in IVF Service Business (2019-2024)
11.5.5 ManorIVF Recent Developments
11.6 Bloom Reproductive Institute
11.6.1 Bloom Reproductive Institute Company Details
11.6.2 Bloom Reproductive Institute Business Overview
11.6.3 Bloom Reproductive Institute IVF Service Introduction
11.6.4 Bloom Reproductive Institute Revenue in IVF Service Business (2019-2024)
11.6.5 Bloom Reproductive Institute Recent Developments
11.7 Fertility First
11.7.1 Fertility First Company Details
11.7.2 Fertility First Business Overview
11.7.3 Fertility First IVF Service Introduction
11.7.4 Fertility First Revenue in IVF Service Business (2019-2024)
11.7.5 Fertility First Recent Developments
11.8 Fertility Associates
11.8.1 Fertility Associates Company Details
11.8.2 Fertility Associates Business Overview
11.8.3 Fertility Associates IVF Service Introduction
11.8.4 Fertility Associates Revenue in IVF Service Business (2019-2024)
11.8.5 Fertility Associates Recent Developments
11.9 Genea Oxford Fertility
11.9.1 Genea Oxford Fertility Company Details
11.9.2 Genea Oxford Fertility Business Overview
11.9.3 Genea Oxford Fertility IVF Service Introduction
11.9.4 Genea Oxford Fertility Revenue in IVF Service Business (2019-2024)
11.9.5 Genea Oxford Fertility Recent Developments
11.10 Boston IVF
11.10.1 Boston IVF Company Details
11.10.2 Boston IVF Business Overview
11.10.3 Boston IVF IVF Service Introduction
11.10.4 Boston IVF Revenue in IVF Service Business (2019-2024)
11.10.5 Boston IVF Recent Developments
11.11 Repromed
11.11.1 Repromed Company Details
11.11.2 Repromed Business Overview
11.11.3 Repromed IVF Service Introduction
11.11.4 Repromed Revenue in IVF Service Business (2019-2024)
11.11.5 Repromed Recent Developments
11.12 The Montreal Fertility Center
11.12.1 The Montreal Fertility Center Company Details
11.12.2 The Montreal Fertility Center Business Overview
11.12.3 The Montreal Fertility Center IVF Service Introduction
11.12.4 The Montreal Fertility Center Revenue in IVF Service Business (2019-2024)
11.12.5 The Montreal Fertility Center Recent Developments
11.13 Sanatorium HELIOS
11.13.1 Sanatorium HELIOS Company Details
11.13.2 Sanatorium HELIOS Business Overview
11.13.3 Sanatorium HELIOS IVF Service Introduction
11.13.4 Sanatorium HELIOS Revenue in IVF Service Business (2019-2024)
11.13.5 Sanatorium HELIOS Recent Developments
11.14 Embryolab
11.14.1 Embryolab Company Details
11.14.2 Embryolab Business Overview
11.14.3 Embryolab IVF Service Introduction
11.14.4 Embryolab Revenue in IVF Service Business (2019-2024)
11.14.5 Embryolab Recent Developments
11.15 Dunya IVF
11.15.1 Dunya IVF Company Details
11.15.2 Dunya IVF Business Overview
11.15.3 Dunya IVF IVF Service Introduction
11.15.4 Dunya IVF Revenue in IVF Service Business (2019-2024)
11.15.5 Dunya IVF Recent Developments
11.16 Klinika Bocian
11.16.1 Klinika Bocian Company Details
11.16.2 Klinika Bocian Business Overview
11.16.3 Klinika Bocian IVF Service Introduction
11.16.4 Klinika Bocian Revenue in IVF Service Business (2019-2024)
11.16.5 Klinika Bocian Recent Developments
11.17 Morpheus IVF
11.17.1 Morpheus IVF Company Details
11.17.2 Morpheus IVF Business Overview
11.17.3 Morpheus IVF IVF Service Introduction
11.17.4 Morpheus IVF Revenue in IVF Service Business (2019-2024)
11.17.5 Morpheus IVF Recent Developments
11.18 Manipal Fertility
11.18.1 Manipal Fertility Company Details
11.18.2 Manipal Fertility Business Overview
11.18.3 Manipal Fertility IVF Service Introduction
11.18.4 Manipal Fertility Revenue in IVF Service Business (2019-2024)
11.18.5 Manipal Fertility Recent Developments
11.19 Cloudnine IVF
11.19.1 Cloudnine IVF Company Details
11.19.2 Cloudnine IVF Business Overview
11.19.3 Cloudnine IVF IVF Service Introduction
11.19.4 Cloudnine IVF Revenue in IVF Service Business (2019-2024)
11.19.5 Cloudnine IVF Recent Developments
11.20 Shanghai Ji Ai Genetics & IVF Institute
11.20.1 Shanghai Ji Ai Genetics & IVF Institute Company Details
11.20.2 Shanghai Ji Ai Genetics & IVF Institute Business Overview
11.20.3 Shanghai Ji Ai Genetics & IVF Institute IVF Service Introduction
11.20.4 Shanghai Ji Ai Genetics & IVF Institute Revenue in IVF Service Business (2019-2024)
11.20.5 Shanghai Ji Ai Genetics & IVF Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IVI-RMA Global
Virtus Health
Southern California Reproductive Center
Monash IVF
ManorIVF
Bloom Reproductive Institute
Fertility First
Fertility Associates
Genea Oxford Fertility
Boston IVF
Repromed
The Montreal Fertility Center
Sanatorium HELIOS
Embryolab
Dunya IVF
Klinika Bocian
Morpheus IVF
Manipal Fertility
Cloudnine IVF
Shanghai Ji Ai Genetics & IVF Institute
Ìý
Ìý
*If Applicable.
